- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
McKesson exec leaves suddenly
Other headlines:Vital Images snags service cert
McKesson exec leaves suddenly
Pam Pure was to be the headliner at McKesson's Healthcare Information and Management Systems Society 2009 media briefing and luncheon, scheduled for April 6, commenting on how the company's products deliver a positive return on investment. But that message will have to come from others in the company. On March 30, Pure abruptly left McKesson, where she had served as president of Technology Solutions for the past five years. The announcement, made March 31, gave no explanation for her departure but stated that "the deep and experienced management team within McKesson Technology Solutions will continue to lead the businesses in the segment." In the prepared statement, chairman and CEO John H. Hammergren expressed "the sincere thanks of everyone at McKesson for her leadership in building McKesson Technology Solutions into what it is today."
Vital Images snags service cert
With service assuming increasing importance in the IT industry, Vital Images hopes to make hay as the first advanced medical visualization provider to achieve certification for Excellence in Service Operations by the Service & Support Professionals Association. The certification ranks the company's support operations, customer satisfaction, service sales and marketing, product serviceability, technology infrastructure, and human resource systems in the same league as those of HP, Cisco, and Xerox, which have received similar certifications, according to Vital Images.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
